• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.

作者信息

Insler S R, Kraenzler E J, Bartholomew J R, Kottke-Marchant K, Lytle B, Starr N J

机构信息

Department of Cardiothoracic Anesthesia, Cleveland Clinic Foundation, Ohio 44195, USA.

出版信息

Anesthesiology. 1997 Feb;86(2):495-8. doi: 10.1097/00000542-199702000-00026.

DOI:10.1097/00000542-199702000-00026
PMID:9054269
Abstract
摘要

相似文献

1
Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.在一名肝素诱导的血小板减少症患者使用类肝素药物Organon 10172期间发生血栓形成。
Anesthesiology. 1997 Feb;86(2):495-8. doi: 10.1097/00000542-199702000-00026.
2
Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.一名接受类肝素药物达那肝素钠治疗的肝素诱导性血小板减少症患者在体外循环时发生凝血并发症。
J Cardiothorac Vasc Anesth. 1997 Dec;11(7):875-7. doi: 10.1016/s1053-0770(97)90124-5.
3
Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.奥加兰（Org 10172）在肝素诱导的血小板减少症患者体外循环中的应用：辅助性血浆置换的作用
J Cardiothorac Vasc Anesth. 1997 Apr;11(2):262-3. doi: 10.1016/s1053-0770(97)90239-1.
4
Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.达那帕罗钠导致的致命性血小板减少症和动脉血栓形成。
Thromb Haemost. 1998 Sep;80(3):530.
5
Heparin-induced thrombocytopenia and thrombosis.肝素诱导的血小板减少症和血栓形成。
Am J Orthop (Belle Mead NJ). 2007 May;36(5):255-60.
6
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.达那肝素治疗肝素诱导的血小板减少症：治疗失败分析
Eur J Haematol. 2003 Aug;71(2):109-13. doi: 10.1034/j.1600-0609.2003.00105.x.
7
[Thrombopenia increased by heparin and danaparoid].[肝素和达那肝素加重血小板减少]
Ann Fr Anesth Reanim. 2001 Jan;20(1):50-3. doi: 10.1016/s0750-7658(00)00333-6.
8
[Current treatment concepts in heparin-induced thrombocytopenia].[肝素诱导的血小板减少症的当前治疗理念]
Dtsch Med Wochenschr. 1999 Jul 16;124(28-29):865-73. doi: 10.1055/s-2007-1024433.
9
Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin.肝素诱导的血小板减少症和血栓形成综合征：与达那肝素的体内交叉反应及重组水蛭素的成功治疗
Br J Haematol. 2001 Aug;114(2):394-6. doi: 10.1046/j.1365-2141.2001.02943.x.
10
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.接受心脏手术的肝素诱导的血小板减少症患者的替代抗凝管理策略。
J Cardiothorac Vasc Anesth. 2007 Feb;21(1):113-26. doi: 10.1053/j.jvca.2006.08.011. Epub 2006 Oct 24.

引用本文的文献

1
Danaparoid: a review of its use in thromboembolic and coagulation disorders.达那肝素：关于其在血栓栓塞和凝血障碍中应用的综述
Drugs. 2002;62(15):2283-314. doi: 10.2165/00003495-200262150-00016.
2
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.肝素诱导的血小板减少症患者的管理：聚焦重组水蛭素
J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:47-57. doi: 10.1023/a:1027333320023.
3
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
达那肝素。其药理学及在肝素诱导的血小板减少症管理中的临床应用综述。
Drugs. 1997 Dec;54(6):903-24. doi: 10.2165/00003495-199754060-00008.